DIAPH1 mutations predict a favorable outcome for de novo MDS
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.217125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Yaqiong Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suz…. Hauptthemen laut MEDLINE: Formins, Myelodysplastic Syndromes, Frameshift Mutation, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Science and Technology Bureau.
Abstract (Originalsprache)
DIAPH1, a member of the formins family and a Rho effector, was found to be involved in thrombocytopoiesis, and the process of MDS in mice with unknown pathogenesis. In this study, we reported a preliminary study about the heterogeneity in the clinical features and outcomes of DIAPH1 mutations in MDS. DIAPH1 frameshift mutations were identified in 20 out of 88 MDS patients, including 11 frameshift mutations locating at 140892588-141000567 (5q31.3), which causes structure changes at FH1 domain. DIAPH1 mutated cases were correlated with lower megakaryocyte dysplasia in lower-risk patients (IPSS-M score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborati…
- Suzhou Hongci Hematology Hospital, Suzhou, China.
Förderung
- National Natural Science Foundation of China
- Jiangsu Province Science and Technology Bureau
Zitieren
APA
Tang, Y., Wang, H., Zhang, Z., Yao, Y., Han, Y., & Wu, D. (2024). DIAPH1 mutations predict a favorable outcome for de novo MDS. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217125
Vancouver
Tang Y, Wang H, Zhang Z, Yao Y, Han Y, Wu D. DIAPH1 mutations predict a favorable outcome for de novo MDS. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217125
BibTeX
@article{Tang2024,
author = {Tang, Yaqiong and Wang, Hong and Zhang, Ziyan and Yao, Yifang and Han, Yue and Wu, Depei},
title = {DIAPH1 mutations predict a favorable outcome for de novo MDS},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.217125}
}
EUVIMED